Page 1 of Clinical Trials for Drug XRP6976 Docetaxel Taxotere, 41 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Japanese Study of the Combined Administration of Docetaxel With Prednisolone for Metastatic Hormone Refractory Prostate Cancer
Last Updated: September 30, 2009
Condition(s): Therapy, Prostatic Neoplasms
2
Completed
Docetaxel in Combination With Cisplatin-5-fluorouracil for the Induction Treatment of Nasopharyngeal Carcinoma in Children and Adolescents
Last Updated: January 27, 2012
Condition(s): Nasopharyngeal Neoplasms; Carcinoma
3
Completed
A Study of Intravenous Aflibercept With Docetaxel in Chinese Patients With Solid Tumors
Last Updated: January 12, 2012
Condition(s): Neoplasm Malignant
4
Recruiting
Cabazitaxel Versus Docetaxel Both With Prednisone in Patients With Metastatic Castration Resistant Prostate Cancer
Last Updated: April 13, 2012
Condition(s): Prostate Cancer
5
Completed
Study With Modafinil in Patients Treated With Docetaxel-Based Chemotherapy for Metastatic Breast or Prostate Cancer (MOTIF)
Last Updated: May 2, 2011
Condition(s): Prostatic Neoplasms; Breast Cancer
6
Recruiting
Docetaxel+Oxaliplatin+S-1 (DOS) Regimen as Neoadjuvant Chemotherapy in Advanced Gastric Cancer
Last Updated: April 18, 2012
Condition(s): Gastric Cancer
7
Not yet recruiting
Continued Treatment With Docetaxel Versus Switch to Cabazitaxel After Minor Prostate Specific Antigen Response to Docetaxel in Patients With Castration-Resistant Metastatic Prostate Cancer
Last Updated: April 11, 2012
Condition(s): Prostatic Neoplasms
8
Completed
Taxotere (Docetaxel) in 1st Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Last Updated: January 19, 2011
Condition(s): Head and Neck Neoplasms; Neoplasm Recurrence, Local; Neoplasm Metastasis
9
Completed
Randomized Multicenter Study Comparing Docetaxel Plus Cisplatin and 5-FU to Cisplatin Plus 5-FU in Advanced Gastric Cancer
Last Updated: April 28, 2009
Condition(s): Stomach Neoplasm
10
Terminated
To Determine the Objective Response Rate of 4 Cycles of Docetaxel + Anthracycline (Epirubicin or Doxorubicine) Followed by 4 Cycles of Docetaxel Single Agent
Last Updated: May 29, 2009
Condition(s): Breast Neoplasms
11
Completed
Induction Chemotherapy Comparing Taxotere® Cisplatin and 5-Fluorouracil (TPF) With Standard Cisplatin and 5-Fluorouracil (PF) Followed by Chemoradiation in Locally Advanced Head and Neck Cancer
Last Updated: April 28, 2009
Condition(s): Cancer
12
Completed
Pilot Efficacy Study of PI-88 With Docetaxel to Treat Prostate Cancer
Last Updated: June 13, 2011
Condition(s): Prostate Cancer
13
Completed
NPC Study : TAX + CIS Neoadjuvant in Patients With Loco Regionally Advanced Undifferentiated Carcinoma of Nasopharyngeal Type (UCNT)
Last Updated: June 23, 2009
Condition(s): Head and Neck Neoplasms
14
Active, not recruiting
Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Advanced Breast Cancer
Last Updated: February 10, 2011
Condition(s): Breast Cancer
15
Completed
A Phase II Trial of Adjuvant Docetaxel in Patients At High Risk of Relapse Following Prostatectomy
Last Updated: June 7, 2011
Condition(s): Prostate Cancer
16
Terminated
Combination of Docetaxel + Estramustine + Hydrocortisone Versus Docetaxel + Prednisone in Patients With Advanced Prostate Cancer
Last Updated: November 29, 2010
Condition(s): Prostatic Neoplasms
17
Terminated
Docetaxel + Doxorubicin as Neoadjuvant Chemotherapy in Patients With Breast Cancer
Last Updated: April 1, 2008
Condition(s): Ductal Carcinoma
18
Completed
Adjuvant Leuprolide With or Without Docetaxel in High Risk Prostate Cancer After Radical Prostatectomy
Last Updated: January 25, 2012
Condition(s): Prostatic Neoplasms
19
Completed
Docetaxel in Hormone Refractory Prostate Cancer (HRPC)[Weekly or 3weekly TAX + Prednisone in HRPC]
Last Updated: December 4, 2009
Condition(s): Prostatic Neoplasms
20
Completed
Neoadjuvant Docetaxel Plus Cisplatin and 5-fluorouracil (TPF) Followed by Concomitant Chemoradiotherapy and Chemoradiotherapy Alone in Locally Advanced Squamous Cell Carcinoma of the Head and Neck Patients (SCCHNS)
Last Updated: December 4, 2009
Condition(s): Head and Neck Neoplasms

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+XRP6976+Docetaxel+Taxotere

Page 1 of Clinical Trials for Drug XRP6976 Docetaxel Taxotere, 41 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About